Cuts proposed by the Trump administration and House Republicans could drive up new HIV cases by more than 200,000 by 2030, one expert projects.
A long-acting HIV jab promises near-perfect protection at just $40 a year, but 115 nations must wait for India's approval of generic production ...
In a bold step towards tackling the HIV epidemic, the Ministry of Health and Wellness is now considering a pilot programme for the first US Food and Drug Administration-approved injectable HIV ...
Two Indian generic drugmakers — Hetero and Dr Reddy’s — will be funded by the Gates Foundation and Unitaid, respectively, to produce and sell the twice-a-year anti-HIV shot, lenacapavir, for $40 ...
Two Indian drugmakers, Hetero Pharma & Dr Reddy’s Laboratories, set to produce generic lenacapavir. The generic version will be available in low- and middle-income countries at significantly lower ...
Kampala, Uganda | THE INDEPENDENT & AGENCIES | A new long-acting medicine that could make preventing HIV transition might soon be even for poor countries like Uganda thanks to agreements between ...
Kampala — THE INDEPENDENT & AGENCIES | A new long-acting medicine that could make preventing HIV transition might soon be even for poor countries like Uganda thanks to agreements between producers and ...
Rough Draft Atlanta on MSN

AIDS Walk raises $1 million for HIV care

The LGBTQ+ community and its allies gathered for the 34th Annual AIDS Walk Music Festival and 5k Run on Sept. 27, raising $1 million for HIV/AIDS prevention and treatment services. The event at ...
President Yoweri Museveni has indicated that the Ugandan economy will reap big from the knowledge economy, that includes biotechnology breakthroughs led by Dr. Matthias Magoola, the Founder of ...
Taking place on 29–30 October in Birmingham, UK, Lab Innovations will gather scientists, researchers, engineers, industry leaders and innovators to engage in two days of focused discussion, knowledge ...
CND Thematic Discussions 30 September 2025. Mr. Chair, Excellencies, Ladies and gentlemen, I am pleased to address you at thi ...